Groundbreaking project seeks to illuminate the complexities of Parkinson’s

Launching today, Landmark is a groundbreaking three-year research programme that aims to understand Parkinson’s in unprecedented detail. The project brings together Parkinson’s UK, Imperial College London, GSK, Novartis, Roche and UCB for the first time, and has been made possible by a founding gift of £4 million from the Gatsby charitable foundation.

Roche wins CE mark for its first CGM

Dive Brief: Roche said Tuesday it has received a CE mark for its Accu-Chek Smartguide continuous glucose monitor (CGM). The clearance positions Roche to challenge

July 10, 2024

Which drugs are most likely to be approved in Non-infectious Uveitis?

Non-infectious Uveitis disease is an indication for drug development with over 10 pipeline drugs currently active according to GlobalData.

March 28, 2024

Predicting behavior from image features: Insights from cortical tuning

Researchers investigate whether the human occipital-temporal cortex (OTC) co-represents the semantic and affective content of visual stimuli to guide behavior.

July 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.